Security key
42328V801
HELIUS MEDICAL TECHNOLOGIES, INC. - COM CL A NEW (HSDT)
CUSIP: 42328V801
Q1 2025 13F Holders as of 31 Mar 2025
- Security type / class
- Equity / COM CL A NEW
- Total 13F shares
- 202,682
- Total 13F value
- $81,276
- Share change
- -11,182
- SEC-reported price per share
- $0.40
- Number of holders
- 13
- Value change
- -$38,447
- Number of buys
- 6
- Number of sells
- 8
Report period
Q1 2025
Institutions
13
Top holders
10
HSDT full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Solana Co SEC filings
Solana Co company facts
Broader feeds
Reporting periods
Holder history for CUSIP 42328V801
Recent filing periods:
Ownership snapshot
Top reported holders of HSDT - HELIUS MEDICAL TECHNOLOGIES, INC. - COM CL A NEW (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ARMISTICE CAPITAL, LLC
Disclosed value leader
Mitch E. Tyler
Comparable rows
1/15
Latest evidence
31 Mar 2025
13D/G
3/4/5
13F
Lead comparable stake: 10%
14 rows are not safely comparable across share classes.
13D/G row: ARMISTICE CAPITAL, LLC
Showing 1-6 of 15 holder rows.
Quick read
ARMISTICE CAPITAL, LLC leads the comparable SEC ownership view at 10%.
1 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ARMISTICE CAPITAL, LLC's linked filing trail.
Comparable ownership
Top 1
ARMISTICE CAPITAL, LLC
10%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
13D/G
|
10%
Reported 13D/G
· 31 Mar 2025
|
—
871,134 shares
|
$0 | 31 Mar 2025 |
| Mitch E. Tyler |
3/4/5
Director
|
—
mixed-class rows
|
$130,823
27,701 shares
mixed-class rows
|
— | 25 May 2021 |
| Virtu Financial LLC |
13F
Company
|
—
denominator unverified
|
$31,000
46,510 shares
|
— | 31 Dec 2024 |
| Grant Private Wealth Management Inc |
13F
Company
|
—
denominator unverified
|
$24,930
37,193 shares
|
— | 31 Dec 2024 |
| UBS Group AG |
13F
Company
|
—
denominator unverified
|
$19,790
29,537 shares
|
— | 31 Dec 2024 |
| TWO SIGMA SECURITIES, LLC |
13F
Company
|
—
denominator unverified
|
$17,585
26,235 shares
|
— | 31 Dec 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
13
Shares
202,682
Rows available
13
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2025 vs Q4 2025 Across Filers
Q4 2025 holders
1
Q1 2025 holders
13
Holder diff
12
| Investor | Q4 2025 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2025 value | Q1 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend